Clinical trial
The Safety of Multiple Intrathecal Injection of Bone Marrow Derived CD133 Cells in Patients With Cerebral Palsy
NCT01763255 is registered in ClinicalTrials.gov with Royan Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety of Multiple Intrathecal Injection of Bone Marrow Derived CD133 Cells in Patients With Cerebral Palsy
- Lead sponsor
- Royan Institute
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- April 30, 2014
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.